Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04939506 · ClinicalTrials.gov registry record · NA
COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana
A NA study, sponsored by Xavier University of Louisiana..
- Completed
- Registry status
- NA
- Development phase
- 379
- Enrollment target
NCT04939506: Completed NA study, sponsored by Xavier University of Louisiana..
NCT04939506 is a NA study that has completed, run by Xavier University of Louisiana.. The registered enrollment target is 379 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04939506, a NA study, has completed, sponsored by Xavier University of Louisiana..
- COMPLETED
- Registry status
- NA
- Development phase
- 379 participants
- Enrollment target
Study Summary
This project is a 2-year study to investigate vaccine hesitancy and vaccine completion among vulnerable communities in the Southeastern Louisiana region. This study will be used to track COVID-19 vaccine completion among patients who seek testing, either as in-person or purchasing at home COVID testing, from pharmacies, urgent cares and clinics using a rapid vaccine education model delivered at the point of care.
Primary Outcome
COVID-19 vaccination completion verified by the Louisiana LINKS© system, defined as receipt of all recommended doses of a COVID-19 vaccine during the 9-month intervention period following education at the point of COVID-19 testing.
Interventions
- BEHAVIORAL COVID-19 Vaccine Education at the Point of COVID-19 Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2024-01-25 |
| Phase | NA |
What the finished NCT04939506 record still lists
NCT04939506 is an interventional study that assigns participants to a tested intervention. The registered 379 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 1 intervention - of which COVID-19 Vaccine Education at the Point of COVID-19 Testing is the first listed.
NCT04939506 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04939506 about?
NCT04939506 is a clinical study titled "COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana". This project is a 2-year study to investigate vaccine hesitancy and vaccine completion among vulnerable communities in the Southeastern Louisiana region. This study will be used to track COVID-19 vaccine completion among patients who seek testing, either as in-person or purchasing at home COVID test...
What is the current status of trial NCT04939506?
This trial is currently completed. It is a NA study. The enrollment target is 379 participants. The study started on 2022-09-01. Estimated completion is 2024-01-25.
What interventions are being tested in trial NCT04939506?
The interventions under investigation include: COVID-19 Vaccine Education at the Point of COVID-19 Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT04939506?
This trial is sponsored by Xavier University of Louisiana., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04939506's enrollment target sits among peer trials
379 274th of 2000 higher than 1,727 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI